💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for EXACT Sciences Corporation (EXAS)
« Back to company indexEXAS Chatter Timeline
Stock Ticker for EXAS
Most Active Tweeters for EXAS
| User | Tweets |
|---|---|
| @mediasentiment | 9 |
| @sleekoptions | 7 |
| @WALLSTREETODDS_ | 5 |
| @FlashAlert_me | 4 |
| @StckPro | 4 |
Recent Tweets for EXAS
 |
@XtradesOfficial $EXAS in a nice weekly demand. Good mid- or long-term swing in my opinion, if these levels hold - C. Halden… https://t.co/igapobgcfV 2:05am |
 |
@Hedgeye " $EXAS remains a Best Idea Short - There should be some relief for the stock today based on the drawdown heading i… https://t.co/MUAeqKnMpE 12:05am |
|
@XtradesOfficial $EXAS in a nice weekly demand. Good mid- or long-term swing if these levels hold - C. Halden #trading #stocks… https://t.co/ppd8qDh8tT May 8th 2021, 12:05pm |
 |
@mediasentiment $EXAS new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 149 May 8th 2021, 11:05am |
 |
@lesismore5050 RT @fakeaccountasdf: Caught the 2-1-2 reversal on $EXAS using #TheStrat. Rode that horse all the way down to close. Probably the most excit… May 8th 2021, 6:05am |
 |
@fakeaccountasdf Caught the 2-1-2 reversal on $EXAS using #TheStrat. Rode that horse all the way down to close. Probably the most ex… https://t.co/Lp8vlQhLIy May 8th 2021, 1:05am |
 |
@sleekoptions $EXAS Was up 2.52 %. Turned negative -3.15% | (Green to red move) #GreenToRed https://t.co/GVxlCwgmt1 https://t.co/1kGcb276jX May 8th 2021, 1:05am |
 |
@TradeWithAlerts Nice Print for $EXAS - Amount: $12,437,799.00 - to learn more, SIGNUP https://t.co/JWvlYbdLod or get a training https://t.co/0L4k6hWHAt! May 7th 2021, 8:05pm |
 |
@DI_Prints Adding $EXAS here on my long term portfolio. Love it. May 7th 2021, 7:05pm |
 |
@pbay08 $exas Added to my position today. The down turn was too much, too fast. GL https://t.co/NBxB15ZMK5 May 7th 2021, 3:05pm |
 |
@WALLSTREETODDS_ $EXAS Out of the 257 other times EXAS was down 4.6% during a trading day, 58% of the time it traded higher by the… https://t.co/p2NPVrLy5Z May 7th 2021, 1:05am |
 |
@InsiderAlerts4U $EXAS: New Insider Filing on EXACT SCIENCES CORP's President and CEO KEVIN T CONROY: https://t.co/dFR8rg3TjN May 6th 2021, 9:05am |
 |
@MC_OptionTrades $EXAS earnings move -4.6% vs an expected ±7.9% move https://t.co/lo9W86s8HQ May 6th 2021, 2:05am |
|
@WALLSTREETODDS_ $EXAS Out of the 236 other times EXAS was down 4.8% during a trading day, 58% of the time it traded higher by the… https://t.co/y417PvFNOz May 6th 2021, 1:05am |
 |
@egelandd @SeanDawes @NYCTTrader $pavm ? Holding until it follows the pps growth trajectory of $exas - looking for 50+ in 12-18 mths! All in here May 5th 2021, 8:05pm |
|
@mediasentiment $EXAS new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 861 May 5th 2021, 7:05pm |
 |
@HedgeyeJVenneri Bob's cartoons are awesome. $EXAS has been a tough one since that liquid biopsy conference presentation in late 3Q2… https://t.co/Rxxgcerl9A May 5th 2021, 6:05pm |
|
@Hedgeye " $EXAS remains a Best Idea Short - There should be some relief for the stock today based on the drawdown heading i… https://t.co/SZPY7v6BNB May 5th 2021, 6:05pm |
 |
@digyourfortune @BackpackerFI Hi Danny. Do you tweet your deep dive on $EXAS. Ty May 5th 2021, 6:05pm |
 |
@MihalkoMan $PAVM I like the idea (my idea) of $EXAS buyin the entire IPO for Lucid! Lets see if The Doctor and Stush can make it happen. May 5th 2021, 3:05pm |
 |
@OpenOutcrier $EXAS (+0.8% pre) Exact Sciences (EXAS) Reports Q1 Loss, Tops Revenue Estimates https://t.co/LcwfIATApO May 5th 2021, 12:05pm |
 |
@Jarvis_Alerts $EXAS [Exact Sciences]: SVB Leerink Maintains Outperform Lowers Price Target $180 --> 170 https://t.co/hX4MIWXli4 May 5th 2021, 12:05pm |
 |
@StckPro $EXAS NEW ARTICLE : Exact Sciences Beat Expectations in Q1: Why Investors Didn't Jump for Joy… https://t.co/7t5E6yG3fR May 5th 2021, 10:05am |
 |
@1stOncology #ExactSciences to participate in May #InvestorConferences $EXAS https://t.co/qtLxQ2gHuu May 5th 2021, 9:05am |
|
@WALLSTREETODDS_ $EXAS Out of the 72 other times EXAS was down 7.9% during a trading day, 61% of the time it traded higher by the s… https://t.co/Cpk2WdEO92 May 5th 2021, 9:05am |
 |
@SeekingAlpha $EXAS - Exact Sciences Corporation 2021 Q1 - Results - Earnings Call Presentation. https://t.co/DDUxInSbL1 #economy #markets #stocks May 5th 2021, 7:05am |
 |
@newsfilterio Exact Sciences EPS beats by $0.84, beats on revenue $EXAS https://t.co/eAiY18qMS2 May 5th 2021, 7:05am |
 |
@EarningsAlley Exact Sciences Corporation $EXAS held an earnings call on 5/4/2021. Here are the highlights: May 5th 2021, 7:05am |
 |
@AlbertVilella $EXAS Exact Sciences is an established player in colon cancer screening with cologuard, recently acquiring left, ri… https://t.co/ZYaSod63vJ May 5th 2021, 5:05am |
 |
@SiteFocusHQ $EXAS Earnings Intelligence Analysis of recent earnings identified EXACT Sciences Corp. (NASDAQ: EXAS ) business f… https://t.co/Ku8icxnYVg May 5th 2021, 5:05am |
 |
@Risk75742306 Keep an eye on this. $EXAS https://t.co/cAIpQDf8eC May 5th 2021, 4:05am |
 |
@plustickbid After many weeks of averaging down trying to pick a bottom in $EXAS Cathie Wood starts dumping shares at the lowes… https://t.co/uPyTvgXp8u May 5th 2021, 4:05am |
|
@DI_Prints $exas $112 AH. Will gladly get a long position soon May 5th 2021, 3:05am |
|
@SeekingAlpha $EXAS - Exact Sciences Corporation (EXAS) CEO Kevin Conroy on Q1 2021 Results - Earnings Call Transcript.… https://t.co/EMeoGuLijZ May 5th 2021, 2:05am |
 |
@Gambiste1 RT @thomasmarciano: @Pharmdca Would be cheaper for $EXAS to just buy $PAVM than for them to try & reinvent the wheel themselves. Especially… May 5th 2021, 1:05am |
 |
@MarketChmln $EXAS #ExactSciences declines in after hours trading. See the latest news. https://t.co/sYWNVVbKRI https://t.co/MLMhVIhcOy May 5th 2021, 12:05am |
|
@sleekoptions $EXAS stock trading volume up by +170.69% | 3,127,240 vs 1,155,268 https://t.co/88dX7pJPfb May 5th 2021, 12:05am |
|
@thomasmarciano @Pharmdca Would be cheaper for $EXAS to just buy $PAVM than for them to try & reinvent the wheel themselves. Especi… https://t.co/xi7FnT8Yn4 May 5th 2021, 12:05am |
 |
@QuantchaIdeas StockTwits Trending Alert: Trading recent interest in EXACT SCIENCES $EXAS https://t.co/36s3FFMxA4 May 5th 2021, 12:05am |
|
@WALLSTREETODDS_ $EXAS Out of the 41 other times EXAS was down 9.2% during a trading day, 63% of the time it traded higher by the n… https://t.co/bBTli1Qocd May 4th 2021, 10:05pm |
 |
@EdgarInsider Filing for 10-Q [Quarterly Report] has been made with the SEC: $EXAS EXACT SCIENCES CORP https://t.co/eDMtR55jSp May 4th 2021, 10:05pm |
 |
@Briefingcom $EXAS: Exact Sciences reports Q1 (Mar) results, beats on revs; guides FY21 revs below consensus https://t.co/COAJqH4cIc May 4th 2021, 10:05pm |
 |
@FredRockIS RT @bluff_capital: $EXAS Exact Sciences beats on eps, beats on rev. https://t.co/3i3Z2VnLCJ May 4th 2021, 9:05pm |
|
@mediasentiment $EXAS new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 1612 May 4th 2021, 9:05pm |
|
@newsfilterio Exact Sciences Q1 loss narrows as it beats analyst estimates $EXAS https://t.co/1sPeq7CArM May 4th 2021, 9:05pm |
 |
@MarcJacksonLA $EXAS Exact Sciences Announces First Quarter 2021 Results https://t.co/poCmIuaGAf May 4th 2021, 9:05pm |
 |
@MarketCurrents $EXAS - Exact Sciences Q1 loss narrows as it beats analyst estimates https://t.co/ziBUsmr1nF May 4th 2021, 9:05pm |
 |
@SchrodingersKa2 $EXAS - STELLAR quarterly report, yet funny how some numbskulls think they can fool everyone during AH. Case in poi… https://t.co/JLbERbo640 May 4th 2021, 9:05pm |
 |
@bluff_capital $EXAS Exact Sciences beats on eps, beats on rev. https://t.co/3i3Z2VnLCJ May 4th 2021, 8:05pm |
 |
@TradingHunter2 $EXAS Jul16'21 105 P 1000 Volume vs 149 OI 660.000 USD Volume Underlying price: 115.18 Last Option Price: 6.6 #EXAS https://t.co/pB6oYFzOun May 4th 2021, 8:05pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
Want insights into the biggest revenue-changing events?
Billions of dollars in sales can evaporate overnight as drug patents expire and competitors enter the market.
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
➤ Free Trial
